Risk Inherent in Benefit of Drug/Device Products?

DIA: Driving Insights to Action

February 25, 2020

Dr. Steven Murray, P.E., group vice president and principal engineer at Exponent, was featured in a podcast where he assesses and analyzes potential and failure products from underground lateral piping to surgical heart catheters. "In drugs and medical devices, developers really need to consider where their product lies on the scale of risk: Is this a product where it is impossible to disentangle the benefits from some other risk? Or is this a product that, if anything is even a little bit wrong, the benefit doesn't justify it?" he asks. "We're much more accepting to risks in things like cancer drugs or AIDS drugs, where the risk of death is highly present and you're averting it."

To listen to the full podcast, click here.